Yanoyan, Elsie E.

HRN: 22-49-92  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/24/2026
AMPICILLIN 1GM (VIAL)
07/24/2026
07/25/2026
IVTT
2g
Q6h
THINLY MSAF; PROM X6h
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Intra-abdominalReproductive Tract    Compliance to guidelines: